Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber

NCT07784673 is registered in ClinicalTrials.gov with SurGenTec LLC as lead sponsor.

NCT NCT07784673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber
Lead sponsor
SurGenTec LLC
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2026
Completion date
February 1, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoflo hydrofiber